Roberto Gozalbo-Rovira

Mar 20, 2024 | onlinelibrary.wiley.com | Estela Giménez |Roberto Gozalbo-Rovira |Eliseo Albert |José Luis Piñana

1 INTRODUCTION Monitoring of Cytomegalovirus (CMV) DNA in blood is a cornerstone in the management of CMV infection in the allogeneic hematopoietic stem cell transplant setting (allo-SCT) as it allows timely administration of anti-CMV drugs (preemptive antiviral therapy [PET]) to prevent the occurrence of CMV end-organ disease.1, 2 Commercially available Real-time PCR assays, either performed on whole blood or plasma, are recommended for CMV DNA quantification in the systemic compartment.3...